Philips's Cautious Outlook Unsurprising After Slow Order Intake Growth -- Market Talk

Dow Jones

Feb 20, 2025

1612 GMT - Philips's cautious outlook for this year doesn't surprise after the company posted only slight order intake growth in 2024, ING analysts say in a note. The Dutch medical-device company's order intake grew 2% in the fourth quarter, bringing the annual growth rate to 1%, they say. With that in mind, it's unsurprising that the guidance for 1%-3% organic growth, including continued decline in China in 2025, was also a little weaker than expected, the analysts say. Divisionally, Philips posted a large adjusted Ebita shortfall in its core Diagnosis & Treatment division, offset by better-than-expected results in Connected Care, as the unit is recovering from its Respironics sleep apnea machines recall. Shares are down 12% at 23.81 euros.(helena.smolak@wsj.com)

(END) Dow Jones Newswires

February 19, 2025 11:12 ET (16:12 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2512748143"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2512748143\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2512748143?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-20 00:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2512748143","market":"other","top_or_hot":-1,"title":"Philips's Cautious Outlook Unsurprising After Slow Order Intake Growth -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1612 GMT - Philips's cautious outlook for this year doesn't surprise after the company posted only slight order intake growth in 2024, ING analysts say in a note. The Dutch medical-device company's order intake grew 2% in the fourth quarter, bringing the annual growth rate to 1%, they say. With that in mind, it's unsurprising that the guidance for 1%-3% organic growth, including continued decline in China in 2025, was also a little weaker than expected, the analysts say. Divisionally, Philips posted a large adjusted Ebita shortfall in its core Diagnosis &amp; Treatment division, offset by better-than-expected results in Connected Care, as the unit is recovering from its Respironics sleep apnea machines recall. Shares are down 12% at 23.81 euros.(helena.smolak@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 19, 2025 11:12 ET (16:12 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Philips's Cautious Outlook Unsurprising After Slow Order Intake Growth -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPhilips's Cautious Outlook Unsurprising After Slow Order Intake Growth -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-02-20 00:12</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1612 GMT - Philips's cautious outlook for this year doesn't surprise after the company posted only slight order intake growth in 2024, ING analysts say in a note. The Dutch medical-device company's order intake grew 2% in the fourth quarter, bringing the annual growth rate to 1%, they say. With that in mind, it's unsurprising that the guidance for 1%-3% organic growth, including continued decline in China in 2025, was also a little weaker than expected, the analysts say. Divisionally, Philips posted a large adjusted Ebita shortfall in its core Diagnosis &amp; Treatment division, offset by better-than-expected results in Connected Care, as the unit is recovering from its Respironics sleep apnea machines recall. Shares are down 12% at 23.81 euros.(helena.smolak@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 19, 2025 11:12 ET (16:12 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2512748143","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2512748143","pubTimestamp":1739981520,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1612 GMT - Philips's cautious outlook for this year doesn't surprise after the company posted only slight order intake growth in 2024, ING analysts say in a note. The Dutch medical-device company's order intake grew 2% in the fourth quarter, bringing the annual growth rate to 1%, they say. With that in mind, it's unsurprising that the guidance for 1%-3% organic growth, including continued decline in China in 2025, was also a little weaker than expected, the analysts say. Divisionally, Philips posted a large adjusted Ebita shortfall in its core Diagnosis & Treatment division, offset by better-than-expected results in Connected Care, as the unit is recovering from its Respironics sleep apnea machines recall. Shares are down 12% at 23.81 euros.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4588":"碎股","BK4082":"医疗保健设备","PHG":"飞利浦"},"translate_title":"订单量增长缓慢后，飞利浦的谨慎前景并不令人意外——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PHG":0.9},"content_text":"1612 GMT - Philips's cautious outlook for this year doesn't surprise after the company posted only slight order intake growth in 2024, ING analysts say in a note. The Dutch medical-device company's order intake grew 2% in the fourth quarter, bringing the annual growth rate to 1%, they say. With that in mind, it's unsurprising that the guidance for 1%-3% organic growth, including continued decline in China in 2025, was also a little weaker than expected, the analysts say. Divisionally, Philips posted a large adjusted Ebita shortfall in its core Diagnosis & Treatment division, offset by better-than-expected results in Connected Care, as the unit is recovering from its Respironics sleep apnea machines recall. Shares are down 12% at 23.81 euros.(helena.smolak@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 19, 2025 11:12 ET (16:12 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}